9 November 2019 in Journal of Ultrasound in Medicine
11 March 2023 in Infectious Diseases and Clinical Microbiology
Objective: Fournier’s gangrene (FG) is a rare necrotizing fasciitis affecting genital and perianal areas. This study aimed to provide data on predicting factors, mortality rates, and factors affecting mortality in comparison of survivors and non-survivors in patients with FG. Materials and Methods: This study included a retrospective analysis of patients diagnosed with FG between 2008 and 2018. Results: A total of 97 patients with FG were included in this study. Of the patients, 72 (74%) were male. The mean age was 56.03±13.92 years, and the median was 57 (21-90). The mortality rate was 21.6%. The most frequently isolated microorganism from tissue and blood cultures was Escherichia coli (43%-42%). The median Fournier’s Gangrene Severity Index (FGSI) and Uludağ FGSI (UFGSI) scores were 4 (0-20) and 5 (1-22), respectively. In the univariate model, mortality risk increases 7.18 times (p=0.001) in patients with two or more comorbidities, 1.31 times as the FGSI score increases (p<0.001), 1.28 times as the UFGSI score increases (p<0.001). When the cut-off value was set as 8 for the FGSI score, the sensitivity was 71.43%, and the specificity was 73.68%. The sensitivity was 73.43%, and the specificity was 75% when the cut-off value was set as 6 for the UFGSI score. In the univariate model, the mortality risk of those with hypotension was 6.07 times higher (p=0.003); as the platelet count increased, mortality risk decreased (odds ratio [OR]=0.99; p=0.02). The mortality risk of those hospitalized in the intensive care unit (ICU) was 16.5 times higher than those followed in the ward (p<0.001). In the multivariate model, this ratio was 6.49. Conclusion: We concluded that FGSI and UFGSI scores could be used to predict mortality. Management of FG requires a multidisciplinary approach. Empiric treatment should include carbapenems and be de-escalated once getting the culture results. Authors from different centers should report their experiences to help reveal the ideal treatment and evaluate the consequences. Keywords: Fournier’s gangrene, necrotizing fasciitis, severity index, FGSI, UFGSI
31 August 2021 in MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
Objective: For recurrence of hepatic hydatid, cysts overlooked during surgery, secondary cysts due to the spread of cystic fluid, late postoperative hydatid cyst formation and inadequate treatment are recommended. Factors affecting recurrence were investigated in cases with recurrence. In this retrospective study, data on 199 patients with hepatic hydatid disease treated by surgery in our hospital, between January 1993 and December 2018 were reviewed.Methods: In this study, patients who were operated for hepatic hydatid disease; The relationship between cyst diameters, cyst stages, number of cysts and recurrence was investigated.Results: 84 patients were male and 115 were female. Most of the cases (189 patients- 88.06 %) treated by conservative surgical methods. Remaining’s (8 patients-4.3 %) had total cystectomy or segmental hepatectomy. Recurrence rate was found 5.47%. In that cases, primary operations were done by us, there was no significant differences between cysts’ stages and recurrences. There was not significantly differences between cysts’ number and recurrences, except the patients had 2 cysts (z=2.17, p=0.03).Conclusion: The best way of prevention of the recurrence of hepatic hydatid cysts are complete diagnosis of cysts' classification, localization, and medico-surgical combination. Perioperative medical treatment must be start three days ago before the operation and should be continued for at least 6 months.
1 January 2022 in Journal of Experimental and Clinical Medicine
Following the spread of novel coronavirus (COVID-19) pandemic, surgical associations have issued their different recommendations for managing the acute cholecystitis (AC) clinic during the pandemic. We aimed to examine the effects of the COVID-19 pandemic period on our clinical approach in patients who presented to the emergency department with abdominal pain and were diagnosed with AC. Medical records of patients diagnosed with AC in the emergency room between 11 March 2020 and 10 March 2021 and in the same period of one year before the pandemic were retrospectively reviewed. Patients were divided into 2 groups as COVID-19 period (Group 1) and non-COVID period (Group 2). Demographics and clinical characteristics, treatment modalities, and outcomes of these two groups were compared. The number of patients diagnosed with AC in the emergency department decreased during the ongoing COVID-19 pandemic. When the time between the onset of the complaints and the admission to the emergency service was evaluated, no statistically significant difference was found between the groups (p>0.05). The distribution of cholecystitis type and TG18 severity grading for AC were similar in both groups (p>0.05). While percutaneous cholecystostomy (PC) is more preferred in the treatment of AC during the pandemic period and the number of delayed interval laparoscopic cholecystectomy decreased, AC management was similar in both periods with no significant statistical difference (P>0.05). In conclusion, our clinical approach and management in the treatment of AC did not differ when compared to the pre-pandemic period.
1 January 2020 in Experimental Biomedical Research